Previz Ventures

Previz Ventures is a venture capital firm located in Herzliya, Israel, established in 2012. The firm specializes in early-stage investments, focusing on technology-driven companies within the medical device and healthcare information and communications technology sectors. By targeting innovative startups in these fields, Previz Ventures aims to support the development of cutting-edge solutions that can enhance healthcare delivery and medical practices.

Dan Baruchi

Managing Partner

4 past transactions

ClearCount Medical Solutions

Series B in 2015
ClearCount Medical Solutions specializes in patient safety solutions for the operating room, focusing on the prevention of medical errors. The company has developed an innovative sponge management system that integrates counting and detection capabilities, enhancing surgical efficiency and patient safety. Utilizing radio frequency identification (RFID) technology, ClearCount's platform enables quick reconciliation of sponge counts during procedures. In cases where a count does not reconcile, the SmartWand™ device assists in locating any missing sponges, further minimizing risks associated with retained surgical items. Through these advancements, ClearCount Medical Solutions aims to improve operational efficiency in surgical environments while ensuring better outcomes for patients.

Clear-Cut Medical

Series B in 2015
ClearCut Medical is focused on transforming cancer surgery and pathology by providing real-time feedback on surgical margins during procedures. The company addresses the challenges faced in achieving complete cancer removal while preserving healthy tissue, as a significant percentage of surgeries do not meet these objectives initially. ClearCut Medical has developed the ClearSight surgical MRI, a compact and mobile device designed for intra-operative use that offers rapid and accurate imaging, outperforming traditional histopathology methods which deliver results days after surgery. This innovation aims to enhance surgical outcomes and decrease the necessity for re-operations and follow-up treatments. Initially targeting breast-conserving surgery, the company operates within a total addressable market of $1.2 billion in the US and Europe, with plans to expand into other cancers, including lung cancer. ClearCut Medical’s business model is centered on a high-margin, single-use tissue container, distinguishing it from conventional capital equipment approaches.

Giraffic

Series A in 2013
Giraffic, Inc. specializes in video-on-demand streaming acceleration technology, which allows online content providers to deliver high-definition video and rich media with minimal interruptions. Founded in 2008 and based in Tel-Aviv, Israel, Giraffic's technology enables simultaneous data retrieval from multiple sources, effectively eliminating re-buffering during video playback. The company initially led the market in multimedia software acceleration, with its Adaptive Video Acceleration (AVA) technology enhancing the reliability of streaming services like Netflix. Following the acquisition of AVA technology by Roku, Giraffic shifted focus to the data cloud storage sector, developing its Distributed Adaptive Storage (DASS) platform. This platform supports distributed and hybrid cloud solutions and offers a consumer backup application designed to provide virtually infinite storage capabilities. Giraffic's innovations have allowed media companies and content distributors to enhance their services significantly, accelerating streaming speeds and reducing buffering challenges across various devices.

Cellrox

Series A in 2013
Cellrox Ltd. is a Tel-Aviv-based company that specializes in mobile virtualization solutions. Founded in 2011, it offers Thinvisor, a lightweight platform that allows multiple secure virtual mobile instances to operate simultaneously on a single device. This technology is designed to facilitate the adoption of smartphones and tablets within corporate IT departments, enabling organizations to create customized and secure mobile environments for their employees. By providing independent virtual environments, Cellrox aims to enhance privacy and control over sensitive information, thereby reducing corporate risk associated with mobile device usage. The company is privately held and is led by experienced entrepreneurs and technology leaders.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.